Frank Greenway, MD, is Medical Director and Professor at Pennington Biomedical Research Center of the Louisiana State University (LSU) System. He graduated from Stanford University, UCLA Medical School, and undertook his internal medicine and endocrinology training at Harbor-UCLA Medical Center. Dr. Greenway served in the US Army California National Guard and was discharged as a Major, Medical Corp. He practiced internal medicine and endocrinology in Marina de Rey, CA, from 1975 to 1995 and taught at Harbor-UCLA, rising to the rank of Professor. He has been in his present position since 1995. Dr. Greenway’s research is creating better treatments for obesity and insulin resistance, including pharmaceuticals, devices, and supplements. Dr. Greenway’s lab uses human fat cells to find pharmacological properties in foods to treat obesity and diabetes. He belongs to the American College of Physicians (fellow), Obesity Society (Fellow), Obesity Medicine Association (fellow), American Society of Nutrition, and Endocrine Society. Dr. Greenway was awarded a scholarship for Eagle scouts to Stanford University, a UCLA School of Medicine Alumni Award, a Distinguished Teaching award - Harbor-UCLA, was a member of the US FDA Endocrine Advisory committee, won educator and research awards - Obesity Medicine Association and Master of American Board of Obesity Medicine. He has several patents and has published over 300 peer-reviewed journal articles.
Frank Greenway, MD, is Medical Director and Professor at Pennington Biomedical Research Center of the Louisiana State University (LSU) System. He graduated from Stanford University, UCLA Medical School, and undertook his internal medicine and endocrinology training at Harbor-UCLA Medical Center. Dr. Greenway served in the US Army California National Guard and was discharged as a Major, Medical Corp. He practiced internal medicine and endocrinology in Marina de Rey, CA, from 1975 to 1995 and taught at Harbor-UCLA, rising to the rank of Professor. He has been in his present position since 1995. Dr. Greenway’s research is creating better treatments for obesity and insulin resistance, including pharmaceuticals, devices, and supplements. Dr. Greenway’s lab uses human fat cells to find pharmacological properties in foods to treat obesity and diabetes. He belongs to the American College of Physicians (fellow), Obesity Society (Fellow), Obesity Medicine Association (fellow), American Society of Nutrition, and Endocrine Society. Dr. Greenway was awarded a scholarship for Eagle scouts to Stanford University, a UCLA School of Medicine Alumni Award, a Distinguished Teaching award - Harbor-UCLA, was a member of the US FDA Endocrine Advisory committee, won educator and research awards - Obesity Medicine Association and Master of American Board of Obesity Medicine. He has several patents and has published over 300 peer-reviewed journal articles.